BMXMF (BioMerieux) FFO


BMXMF BioMerieux SA BMXMF
67 GF Score
Price $82.78
GF Value $127.91
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is BioMerieux FFO?

FFO (Funds from operations) only applies to REITs.

BMXMF
67GF Score
BioMerieux SA BMXMF
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioMerieux (BMXMF) Overvalued in 2026?

Based on GuruFocus' analysis, BioMerieux stock appears to be undervalued. The current stock price of $82.78 is trading 35.3% below its estimated GF Value™ of $127.91. GuruFocus considers BioMerieux to be Significantly Undervalued.

Key valuation signals for BMXMF:

  • FFO:
  • GF Value™: $127.91 vs. price of $82.78 (35.3% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BMXMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioMerieux Business Description

Address Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMérieux is headquartered in Marcy-l'Étoile, France.
67GF Score

Get the complete analysis for BMXMF

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.78
Price
$127.91
GF Value